Login / Signup

Ceftolozane-tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability study.

Edward RabySaiyuri NaickerFekade Bruck SimeLaurens ManningSteven C WallisSaurabh PandeyJason A Roberts
Published in: European journal of hospital pharmacy : science and practice (2019)
Ceftolozane-tazobactam is suitable for ambulatory care delivered as a continuous infusion via an elastomeric infusion device.
Keyphrases
  • gram negative
  • low dose
  • healthcare
  • blood pressure
  • palliative care
  • quality improvement
  • multidrug resistant
  • pain management
  • affordable care act
  • chronic pain
  • health insurance